Global Cryosurgery Devices Market
Market Size in USD Billion
USD
3.45 Billion
USD
4.79 Billion
2025
2033
Forecast Period |
2026 - 2033 |
Market Size (Base Year) |
USD 3.45 Billion |
Market Size (Forecast Year) |
USD 4.79 Billion |
CAGR |
% |
Major Markets Players |
|
Forecast Period
Market Size (Base Year)
Market Size (Forecast Year)
CAGRWhat is the Cryosurgery Devices Market Size and Growth Rate?
- As per Data Bridge Market Research analysis the cryosurgery devices market was valued at USD 3.45 billion in 2025 and is projected to reach USD 4.79 billion by 2033, growing at a CAGR of 4.20% from 2026 to 2033.
- The market is experiencing steady growth driven by the increasing adoption of minimally invasive treatment procedures, rising prevalence of cancer and other chronic diseases, and growing demand for targeted cryotherapy solutions across various medical applications.
- Technological advancements in cryosurgery devices, combined with increasing healthcare expenditure and expanding applications in oncology, dermatology, gynecology, and ophthalmology, are further supporting market growth.
Market Size & Forecast
- Market Value (2025): USD 3.45 Billion
- Expected Market Value (2033): USD 4.79 Billion
- Forecast CAGR (2026–2033): 4.20%
- Leading Region in 2025: North America
- Fastest Growing Region: Asia-Pacific
What are the Major Takeaways of the Cryosurgery Devices Market?
- North America dominated the cryosurgery devices market with the largest revenue share in 2025, supported by the increasing prevalence of cancer and chronic diseases, strong healthcare infrastructure, and growing adoption of minimally invasive treatment procedures.
- Asia-Pacific cryosurgery devices market is expected to witness the fastest growth rate from 2026 to 2033, supported by the rising prevalence of cancer, expanding healthcare infrastructure, increasing healthcare expenditure, and growing awareness of minimally invasive treatment options.
- The oncology segment held the largest market revenue share in 2025, driven by the increasing adoption of cryoablation for targeted treatment of tumors and the rising prevalence of cancer. Cryosurgery is increasingly preferred in selected cancer treatments due to its minimally invasive nature, precise tissue destruction, reduced surgical trauma, and shorter recovery time.
- The dermatology segment is projected to register the fastest growth at a CAGR from 2026 to 2033, driven by increasing demand for minimally invasive treatment of skin lesions, warts, actinic keratosis, and other dermatological conditions. Growing awareness of cryotherapy procedures and expanding adoption of advanced cryotherapy devices in dermatology clinics are accelerating segment expansion.
- The cryoablation devices segment held the largest market revenue share in 2025, driven by increasing utilization in oncology and other minimally invasive surgical applications. Cryoablation devices are preferred due to their ability to deliver controlled freezing directly to targeted tissues while minimizing damage to surrounding healthy tissue.
- The cryotherapy probes segment is projected to register the fastest growth at a CAGR from 2026 to 2033, driven by increasing demand for precise and localized cryosurgical procedures across dermatology, oncology, and gynecology. Technological advancements in probe design and temperature control are further supporting segment expansion.
Report Scope and Cryosurgery Devices Market Segmentation
|
Attributes |
Cryosurgery Devices Key Market Insights |
|
Segments Covered |
|
|
Countries Covered |
North America
Europe
Asia-Pacific
Middle East and Africa
South America
|
|
Key Market Players |
|
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. |
What is the Key Trend in the Cryosurgery Devices Market?
- Healthcare providers are increasingly adopting image-guided and minimally invasive cryoablation technologies that enable precise targeting of diseased tissue while reducing damage to surrounding healthy tissue and supporting faster recovery.
- For instance, in November 2024, the U.S. Food and Drug Administration (FDA) convened its General and Plastic Surgery Devices Panel to discuss IceCure Medical’s ProSense Cryoablation System for the treatment of low-risk breast cancer, highlighting increasing clinical and regulatory attention toward cryosurgery applications.
- Advanced cryosurgery systems are incorporating improved temperature control, specialized cryoprobes, and integrated monitoring technologies to enhance treatment precision and procedural efficiency.
- For instance, Medtronic’s CryoConsole system is designed to power and regulate the temperature of approved cryoablation catheters used in cardiac arrhythmia procedures, demonstrating the continued development of controlled cryotherapy technologies.
- As minimally invasive treatment approaches gain acceptance and manufacturers continue improving temperature control, precision, and procedural workflow, advanced cryosurgery devices are expected to gain wider adoption across oncology, cardiology, dermatology, and other therapeutic applications.
What are the Key Drivers of the Cryosurgery Devices Market?
- The rising prevalence of cancer and growing demand for minimally invasive treatment procedures are increasing the adoption of cryoablation technologies, particularly for targeted destruction of abnormal or cancerous tissue.
- For instance, in March 2026, IceCure Medical announced that the U.S. FDA had approved its post-market ChoICE study for ProSense cryoablation in the local treatment of low-risk breast cancer, with patient enrollment expected to begin in the second half of 2026 and at least 80 patients targeted for enrollment during the first year.
- Cryosurgery is gaining traction because it can destroy targeted tissue through controlled freezing while avoiding the extensive incisions associated with conventional surgical procedures, supporting outpatient treatment in selected applications.
- For instance, Medtronic’s cryoablation portfolio includes the Nitron CryoConsole, which supports its Arctic Front and Freezor families of cardiac cryoablation catheters for treating cardiac arrhythmias.
- With increasing demand for targeted and less invasive therapies, expanding clinical applications, and continued investment in cryotherapy technologies, cryosurgery devices are expected to witness sustained adoption across oncology, cardiology, dermatology, and other medical applications.
Which Factors are Challenging the Growth of the Cryosurgery Devices Market?
- Advanced cryosurgery procedures can require specialized cryoprobes, consoles, imaging guidance, trained healthcare professionals, and dedicated infrastructure, increasing the overall cost of treatment and limiting adoption among smaller healthcare facilities.
- Regulatory and clinical-evidence requirements can also slow the expansion of cryosurgery devices into new therapeutic indications, as manufacturers must demonstrate safety, effectiveness, and appropriate clinical outcomes for specific applications.
- For instance, in November 2024, the FDA’s General and Plastic Surgery Devices Panel reviewed the ProSense Cryoablation System for its proposed use in treating low-risk breast cancer, demonstrating the extensive regulatory evaluation required for expanding cryosurgery into new indications.
- In October 2025, the FDA granted De Novo classification to the ProSense System as a cryoablation device for local treatment of low-risk breast cancer, illustrating the regulatory process involved in establishing new device classifications and indications.
- The high cost of advanced equipment, specialized training requirements, and lengthy clinical and regulatory processes continue to restrict widespread adoption, particularly in price-sensitive healthcare systems and emerging markets, despite increasing demand for minimally invasive treatment technologies.
How is the Cryosurgery Devices Market Segmented?
The market is segmented on the basis of application, device type, end user, and technique.
- By Application
On the basis of application, the cryosurgery devices market is segmented into oncology, dermatology, gynecology, urology, and podiatry. The oncology segment held the largest market revenue share in 2025, driven by the increasing adoption of cryoablation for targeted treatment of tumors and the rising prevalence of cancer. Cryosurgery is increasingly preferred in selected cancer treatments due to its minimally invasive nature, precise tissue destruction, reduced surgical trauma, and shorter recovery time.
The dermatology segment is projected to register the fastest growth at a CAGR from 2026 to 2033, driven by increasing demand for minimally invasive treatment of skin lesions, warts, actinic keratosis, and other dermatological conditions. Growing awareness of cryotherapy procedures and expanding adoption of advanced cryotherapy devices in dermatology clinics are accelerating segment expansion.
- By Device Type
On the basis of device type, the cryosurgery devices market is segmented into cryotherapy probes, cryoablation devices, cryoguns, and cryo units. The cryoablation devices segment held the largest market revenue share in 2025, driven by increasing utilization in oncology and other minimally invasive surgical applications. Cryoablation devices are preferred due to their ability to deliver controlled freezing directly to targeted tissues while minimizing damage to surrounding healthy tissue.
The cryotherapy probes segment is projected to register the fastest growth at a CAGR from 2026 to 2033, driven by increasing demand for precise and localized cryosurgical procedures across dermatology, oncology, and gynecology. Technological advancements in probe design and temperature control are further supporting segment expansion.
- By End User
On the basis of end user, the cryosurgery devices market is segmented into hospitals, ambulatory surgical centers, dermatology clinics, and cancer treatment centers. The hospitals segment held the largest market revenue share in 2025, driven by the availability of advanced surgical infrastructure, specialized healthcare professionals, and comprehensive diagnostic and treatment facilities. Hospitals are increasingly adopting cryosurgery devices for oncology, urology, gynecology, and other specialized procedures.
The ambulatory surgical centers segment is projected to register the fastest growth at a CAGR from 2026 to 2033, driven by increasing preference for minimally invasive outpatient procedures, shorter hospital stays, and lower treatment costs. Growing investment in advanced surgical technologies and expanding availability of outpatient cryosurgery services are accelerating segment expansion.
- By Technique
On the basis of technique, the cryosurgery devices market is segmented into contact cryotherapy, percutaneous cryoablation, and open cryosurgery. The percutaneous cryoablation segment held the largest market revenue share in 2025, driven by increasing adoption of minimally invasive tumor treatment procedures and growing demand for image-guided cryoablation. The technique enables targeted tissue destruction through specialized probes inserted directly into the treatment area while reducing surgical trauma.
The contact cryotherapy segment is projected to register the fastest growth at a CAGR from 2026 to 2033, driven by its widespread use in dermatology for treating superficial skin lesions and other localized conditions. Increasing demand for convenient outpatient procedures and growing adoption of cryotherapy in specialized dermatology clinics are supporting segment expansion.
Which Region Holds the Largest Share of the Cryosurgery Devices Market?
- North America dominated the cryosurgery devices market with the largest revenue share in 2025, supported by the increasing prevalence of cancer and chronic diseases, strong healthcare infrastructure, and growing adoption of minimally invasive treatment procedures.
- Healthcare providers in the region are increasingly adopting advanced cryoablation systems for oncology, cardiology, dermatology, and other applications due to their precision and ability to reduce surgical trauma. The presence of leading medical device manufacturers, high healthcare expenditure, and favorable adoption of advanced surgical technologies further establishes North America as a leading market for cryosurgery devices.
U.S. Cryosurgery Devices Market Insight
U.S. cryosurgery devices market captured the largest revenue share in 2025 within North America, fueled by the rising prevalence of cancer, increasing demand for minimally invasive procedures, and widespread availability of advanced healthcare technologies. Hospitals and specialized treatment centers are increasingly adopting cryoablation devices for targeted tissue destruction across oncology, dermatology, urology, and other applications. Moreover, ongoing clinical research, strong healthcare expenditure, and the presence of major medical device companies are significantly contributing to market expansion.
Europe Cryosurgery Devices Market Insight
Europe cryosurgery devices market is expected to witness significant growth from 2026 to 2033, primarily driven by increasing adoption of minimally invasive surgical procedures and the rising prevalence of cancer and dermatological disorders. The region's well-developed healthcare infrastructure and growing focus on reducing hospital stays are fostering the adoption of cryotherapy and cryoablation technologies. European healthcare providers are increasingly integrating advanced cryosurgery systems into oncology, dermatology, gynecology, and urology procedures, supporting market expansion.
U.K. Cryosurgery Devices Market Insight
U.K. cryosurgery devices market is expected to witness significant growth from 2026 to 2033, driven by the increasing demand for minimally invasive treatment options and growing adoption of advanced surgical technologies. The rising burden of cancer and skin disorders is encouraging healthcare providers to adopt targeted cryotherapy and cryoablation procedures. In addition, the U.K.'s established healthcare infrastructure, focus on cost-effective treatment, and increasing availability of specialized surgical centers are expected to stimulate market growth.
Germany Cryosurgery Devices Market Insight
Germany cryosurgery devices market is expected to witness significant growth from 2026 to 2033, fueled by advanced healthcare infrastructure, increasing healthcare expenditure, and growing demand for minimally invasive treatment solutions. The country's strong focus on medical technology and precision treatment supports the adoption of cryosurgery devices across oncology, dermatology, and other applications. Furthermore, increasing investment in advanced medical equipment and the growing prevalence of cancer are contributing to the expansion of cryosurgery technologies in Germany.
Asia-Pacific Cryosurgery Devices Market Insight
The Asia-Pacific cryosurgery devices market is expected to witness the fastest growth rate from 2026 to 2033, supported by the rising prevalence of cancer, expanding healthcare infrastructure, increasing healthcare expenditure, and growing awareness of minimally invasive treatment options. Countries such as China, Japan, and India are witnessing greater adoption of advanced medical technologies as healthcare facilities modernize their treatment capabilities. Furthermore, increasing investments in healthcare infrastructure and the growing presence of international and domestic medical device manufacturers are improving the availability of cryosurgery systems across the region.
Japan Cryosurgery Devices Market Insight
Japan cryosurgery devices market is expected to witness significant growth from 2026 to 2033 due to the country's advanced healthcare infrastructure, aging population, and strong emphasis on innovative medical technologies. The increasing prevalence of cancer and demand for less invasive treatment options are encouraging healthcare providers to adopt cryoablation and cryotherapy technologies. Moreover, Japan's focus on precision medicine, advanced medical equipment, and improving treatment outcomes is supporting the integration of cryosurgery devices across specialized healthcare applications.
China Cryosurgery Devices Market Insight
The China cryosurgery devices market accounted for a significant market revenue share in Asia Pacific in 2025, attributed to the country's growing healthcare expenditure, expanding hospital infrastructure, and rising prevalence of cancer. Increasing government investment in healthcare modernization and greater access to advanced medical technologies are supporting the adoption of minimally invasive treatment procedures. The expansion of domestic medical device manufacturing, improving availability of cryoablation technologies, and increasing demand for cost-effective cancer treatment solutions are further propelling the market in China.
Which are the Top Companies in Cryosurgery Devices Market?
The cryosurgery devices industry is primarily led by well-established companies, including:
- Medtronic plc (Ireland)
- Boston Scientific Corporation (U.S.)
- CooperSurgical, Inc. (U.S.)
- IceCure Medical Ltd. (Israel)
- CryoConcepts LP (U.S.)
- AtriCure, Inc. (U.S.)
- Erbe Elektromedizin GmbH (Germany)
- MicroPort Scientific Corporation (China)
- Metrum Cryoflex Sp. z o.o. (Poland)
- CPSI Biotech (U.S.)
- HealthTronics, Inc. (U.S.)
- Endocare, Inc. (U.S.)
- Sanarus Technologies, Inc. (U.S.)
- Vimecon GmbH (Germany)
- BVM Medical Limited (U.K.)
What are Latest Developments in Cryosurgery Devices Market?
- In October 2022, Channel Medsystems Inc announced the first procedure in Europe using its Cerene Cryotherapy Device to treat heavy menstrual bleeding. The procedure demonstrated the device’s expansion into the European market and provided physicians with a minimally invasive treatment option. This development is expected to support the adoption of cryotherapy for gynecological applications and strengthen the company’s presence in the European cryosurgery devices market.
- In January 2022, Suzhou MicroPort RehabTech Co., Ltd. launched an integrated range of musculoskeletal rehabilitation products in Beijing, including the TherMotion Cryo-Thermo Compression Device and TherMotion Cryotherapy Compression Brace. The products were designed to support rehabilitation following musculoskeletal injuries and orthopedic procedures. The launch expanded the use of cryotherapy in rehabilitation and strengthened the availability of advanced cryotherapy solutions in the Chinese market.
SKU-
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
